These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 15763199)
21. The treatment of metastatic uveal melanoma. Pyrhönen S Eur J Cancer; 1998 Jul; 34 Suppl 3():S27-30. PubMed ID: 9849406 [TBL] [Abstract][Full Text] [Related]
22. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis. Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554 [TBL] [Abstract][Full Text] [Related]
23. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366 [TBL] [Abstract][Full Text] [Related]
24. Prediction of metastasis of uveal melanoma: comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA. McLean IW; Gamel JW Invest Ophthalmol Vis Sci; 1988 Apr; 29(4):507-11. PubMed ID: 3356509 [TBL] [Abstract][Full Text] [Related]
25. The left ventricle as the first site of uveal melanoma metastasis 13 years after treatment of the primary tumor. Kolandjian NA; Patel SP; Papadopoulos NE; Bedikian AY Melanoma Res; 2011 Apr; 21(2):160-3. PubMed ID: 21346640 [TBL] [Abstract][Full Text] [Related]
26. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern. Lindegaard J; Isager P; Prause JU; Heegaard S Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391 [TBL] [Abstract][Full Text] [Related]
27. Osteopontin as a serologic marker for metastatic uveal melanoma: results of a pilot study. Reiniger IW; Wolf A; Welge-Lüssen U; Mueller AJ; Kampik A; Schaller UC Am J Ophthalmol; 2007 Apr; 143(4):705-7. PubMed ID: 17386288 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic options in metastatic uveal melanoma. Mariani P; Servois V; Piperno-Neumann S Dev Ophthalmol; 2012; 49():166-181. PubMed ID: 22042020 [TBL] [Abstract][Full Text] [Related]
29. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826 [TBL] [Abstract][Full Text] [Related]
32. Characterization of ocular and metastatic uveal melanoma in an animal model. Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923 [TBL] [Abstract][Full Text] [Related]
33. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma. O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271 [TBL] [Abstract][Full Text] [Related]
34. Using the direct-injection model of early uveal melanoma hepatic metastasis to identify TPS as a potentially useful serum biomarker. Barak V; Frenkel S; Valyi-Nagy K; Leach L; Apushkin MA; Lin AY; Kalickman I; Baumann NA; Pe'er J; Maniotis AJ; Folberg R Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4399-402. PubMed ID: 17898257 [TBL] [Abstract][Full Text] [Related]
35. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation. Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854 [TBL] [Abstract][Full Text] [Related]
36. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
37. Novel cell lines derived by long-term culture of primary uveal melanomas. Nareyeck G; Zeschnigk M; Bornfeld N; Anastassiou G Ophthalmologica; 2009; 223(3):196-201. PubMed ID: 19212147 [TBL] [Abstract][Full Text] [Related]
38. Osteopontin and 'melanoma inhibitory activity': comparison of two serological tumor markers in metastatic uveal melanoma patients. Haritoglou I; Wolf A; Maier T; Haritoglou C; Hein R; Schaller UC Ophthalmologica; 2009; 223(4):239-43. PubMed ID: 19270465 [TBL] [Abstract][Full Text] [Related]
39. Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects. Baggetto LG; Gambrelle J; Dayan G; Labialle S; Barakat S; Michaud M; Grange JD; Gayet L Cancer Treat Rev; 2005 Aug; 31(5):361-79. PubMed ID: 15994016 [TBL] [Abstract][Full Text] [Related]
40. [Surgical management of orbital malignant melanoma: our experience and a report of three cases]. Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]